Pinnacle Fertility

Pinnacle Fertility

Pinnacle Fertility, led by CEO Beth Zoneraich, operates as a management services organization (MSO) that consolidates independent fertility clinics across the United States. Founded as an administrative and operational platform rather than a medical practice, Pinnacle provides non-clinical support — covering HR, finance, marketing, and regulatory compliance — to a network of over 40 clinics and 50 locations. The structure allows affiliated reproductive endocrinology and infertility (REI) specialists to focus exclusively on patient care while Pinnacle handles practice management. Pinnacle's service lines span the full fertility treatment chain: in vitro fertilization (IVF), intrauterine insemination (IUI), egg freezing, genetic testing, and surrogacy services. The firm also operates a National Egg Bank for donor matching. Patient volumes reported on the firm's website include 20,500 new patients and 10,600 retrieval cycles annually across the network. Ancillary operations include a surrogacy services vertical and a proprietary pharmacy. Pinnacle partners with clinical finance platforms like PatientFi to offer payment solutions, integrating financing directly into the patient intake process. The firm counts over 1,000 team members and 50 REI providers across its network, with its leadership bench including CEO Beth Zoneraich and at least six additional named executives with backgrounds in healthcare operations, finance, and business development. Its website lists detailed executive profiles but no founding date or specific investment structure. Castle Connolly recognized the network as a top-5 fertility group, with 32 physicians named Top Doctors. No disclosed AUM or fund structure appears in any source. What separates Pinnacle's architecture from a traditional fertility chain is its MSO model: it owns no medical practices directly and employs no physicians. Instead, it centralizes corporate functions — marketing, compliance, administrative staffing — while affiliated clinics retain professional corporations that deliver care. This corporate-practice-of-medicine workaround is common in physician-services rollups but less visible in reproductive health, where consolidation has historically been driven by hospital systems rather than stand-alone MSOs.